Duke’s iGEM Team Wins Gold in 2014

Seven Duke undergraduates worked with GCB faculty members Charles Gersbach and Nicholas Buchler to develop a synthetic molecular circuit that was awarded a coveted gold medal at the 2014 international iGEM competition featuring over 100 teams.

Who we are

On July 1st, 2014, the Institute for Genome Sciences & Policy (IGSP) transitioned into several units focusing on distinct topics. Genomic and Computational Biology (GCB) houses interdisciplinary research and education.

GCB is an interdisciplinary center where faculty from across Duke’s campus collaborate to study complex problems in genomic and computational biology, train researchers, and develop genomic technologies.

For more than a decade, the IGSP was all things genomic to Duke. Under Hunt Willard’s leadership, the IGSP fostered scholarship in the genome sciences and in their societal ramifications throughout campus.

GCB Academy

Researchers and ambitious students will find interactive research workshops, specifically tailored to their research goals and aspirations.

Learn more about the Academy

Meet Andrea Moffitt, a 4th year PhD student in our Computational Biology and Bioinformatics Program.

“Sandeep has fostered my development as a computational biologist, giving me the knowledge, the data, and the freedom to explore on the frontier of cancer genomics research.”

“Andrea exemplifies the strengths of the CBB program. Working closely with both "wet-lab" molecular biologists and computational biologists in our group, Andrea has made integrative connections between whole genome sequencing, RNA and CHIP-seq data that is redefining our view of cancer.”

Sandeep Dave Medicine - Oncology

GCB by the numbers

Numbers provide a quick way to understand an organization. Here are some salient features of GCB that tell you a little about who we are and what we do.

  • 17 faculty members

  • 5 core facilities

  • 10 billion bases sequenced / day

  • 119 trainees in labs

  • $9.4 mil. in new research funding

I’ve had such a phenomenal experience working in the Gersbach lab. Even as an undergrad, I was given an empowering degree of independence in my project, accompanied by an uncommon degree of mentorship, support, and access to resources needed to grow as both an engineer and scientist.

Suyash Kumar '16 Biomedical Engineering

Featured researchers

Erich Huang Translational Bioinformatics

Charles Gersbach Biomedical Engineering

Alex Hartemink Computer Science

Raluca Gordan Biostatistics &Bioinformatics

The Duke Proteomics Facility has discovered that the risk of ACL injuries and re-injuries is greater for women than men due to differences in the composition of their connective tissues.

Dr. Arthur Moseley and his team have identified specific proteomic differences between male and female patellar tendon and anterior cruciate ligament and have identified novel pathways which may lead to improved understanding of a differential risk of ACL injury and re-injury in men and women.